We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.07B
AUM Growth
+$251M
Cap. Flow
-$68.7M
Cap. Flow %
-3.32%
Top 10 Hldgs %
44.01%
Holding
2,647
New
722
Increased
455
Reduced
467
Closed
877

Sector Composition

Rank Sector Weight
1 Technology 6.57%
2 Consumer Discretionary 4.71%
3 Industrials 3.64%
4 Healthcare 3.58%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTEV
451
Claritev Corp
CTEV
$581M
$462K 0.02%
+1,126
New +$495K
HAE icon
452
Haemonetics
HAE
$3.94B
$457K 0.02%
5,237
+506
+11% +$44.2K
PJT icon
453
PJT Partners
PJT
$4.33B
$455K 0.02%
+7,500
New +$421K
EOSE icon
454
Eos Energy Enterprises
EOSE
$1.47B
$451K 0.02%
45,060
-26,941
-37% -$278K
QDEL icon
455
QuidelOrtho
QDEL
$938M
$447K 0.02%
2,038
+1,434
+237% +$320K
MCK icon
456
McKesson
MCK
$103B
$445K 0.02%
2,987
+1,885
+171% +$286K
LKQ icon
457
LKQ Corp
LKQ
$6.22B
$444K 0.02%
+15,998
New +$472K
SPOT icon
458
Spotify
SPOT
$105B
$444K 0.02%
1,830
+864
+89% +$223K
NXST icon
459
Nexstar Media Group
NXST
$5.91B
$442K 0.02%
4,911
+1,163
+31% +$105K
HTZ
460
DELISTED
Hertz Global Holdings, Inc.
HTZ
$441K 0.02%
+397,342
New +$572K
GILD icon
461
Gilead Sciences
GILD
$165B
$439K 0.02%
6,940
-1,317
-16% -$91.3K
SRNE
462
CALL
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$439K 0.02%
39,400
-5,700
-13% -$52.2K
HUD
463
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$436K 0.02%
+57,400
New +$348K
HMSY
464
DELISTED
HMS Holdings Corp.
HMSY
$434K 0.02%
+18,120
New +$533K
NOC icon
465
Northrop Grumman
NOC
$82.1B
$433K 0.02%
+1,372
New +$447K
OR icon
466
OR Royalties Inc
OR
$6.32B
$429K 0.02%
36,299
+9,493
+35% +$110K
TBHC
467
DELISTED
The Brand House Collective
TBHC
$426K 0.02%
+51,840
New +$337K
B
468
Barrick Mining
B
$68.5B
$425K 0.02%
15,132
-36,500
-71% -$1.04M
GBT
469
DELISTED
Global Blood Therapeutics, Inc.
GBT
$425K 0.02%
7,705
+1,855
+32% +$118K
TWO
470
Two Harbors Investment
TWO
$1.26B
$422K 0.02%
+20,711
New +$440K
AVGO icon
471
Broadcom
AVGO
$2.01T
$414K 0.02%
11,360
-170,750
-94% -$5.72M
TNA icon
472
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.45B
$410K 0.02%
+13,400
New +$420K
FL
473
DELISTED
Foot Locker
FL
$409K 0.02%
+12,392
New +$378K
CXO
474
DELISTED
CONCHO RESOURCES INC.
CXO
$407K 0.02%
9,230
-29,281
-76% -$1.46M
NBIS
475
Nebius Group N.V.
NBIS
$46.7B
$403K 0.02%
6,178
-572
-8% -$34.1K

Similar funds

Prelude Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prelude Capital Management held 2,647 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prelude Capital Management withdrew a net $68.7M in Q3 2020, closing 877 positions and reducing 467 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Prelude Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $14.9M.

  • Prelude Capital Management's largest Q3 2020 buy was Equitrans Midstream Corporation Common Stock: 1,760,179 shares worth $14.9M.
  • Prelude Capital Management added most to Alibaba in Q3 2020, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q3 2020 reduction was Broadcom, cutting an estimated $5.72M.
  • Prelude Capital Management fully exited Invesco QQQ Trust in Q3 2020, selling an estimated $9.18M.
  • Prelude Capital Management's ten largest holdings make up 44% of its $2.07B portfolio in Q3 2020.
  • Prelude Capital Management opened 722 new positions and closed 877 in Q3 2020.
  • Prelude Capital Management's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.